Status:
RECRUITING
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Collaborating Sponsors:
Congressionally Directed Medical Research Programs
Mayo Clinic
Conditions:
Brain Cancer
Brain Tumor
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess the ability of the home-based intervention, HOBSCOTCH-CA, to improve the quality of life and cognitive function in Service Members, Veterans and civilians who ar...
Detailed Description
The investigators' hypothesis is that the home-based intervention (HOBSCOTCH-CA) will improve quality of life and cognitive function in Service Members, Veterans and civilians with who are survivors o...
Eligibility Criteria
Inclusion
- CA Participants will be referred to the study by their providers (Oncologist) who will be made aware of the study and inclusion/exclusion criteria. Inclusion Criteria 2. - 5. and Exclusion Criteria 1. - 3. will be confirmed by referring providers. Participants who learn about the study here and elsewhere will be instructed on how to confirm their eligibility with their provider.
- Inclusion Criteria for CA Participant:
- 18 + years
- Service members, Veterans and civilians with a diagnosis of brain cancer (excluding glioblastoma)
- Diagnosis of primary brain tumor with expected survival of 2 years or greater (e.g., low-grade glioma, oligodendroglioma, IDH mutant astrocytoma, meningioma) defined as the presence of a primary lesion on neuroimaging (CT or MRI), confirmed by histopathological examination (Note: some patients being treated for meningioma may be treated with radiotherapy without need for initial histopathologic confirmation)
- Patients undergoing surgical and/or radiation therapy will have completed their treatment at least 3 months prior to being enrolled in trial (Note: patients receiving chemotherapy or other systemic therapy will be included)
- Stable on all CNS acting medications for one month prior to enrollment
- Subjective cognitive complaints
- Literate and proficient in English
- Internet access for the pre-session and Session 1 of the HOBSCOTCH-CA program; telephone access for sessions 2-8
- Exclusion Criteria for CA Participant:
- Presence of a neurodegenerative disease (e.g., Alzheimer's disease, Parkinson's disease)
- Acute psychiatric disorder or substance abuse
- Patients with glioblastoma (GBM)
- Inclusion Criteria for CA Participant Caregiver:
- Age 18 +
- Caregiver to a patient with a confirmed diagnosis of brain cancer/tumor survivor
- CA Subject has given permission for their caregiver to participate
- Literate and proficient in English
- Internet access (for Pre-HOBSCOTCH and Session 1)
- Telephone access (for Session 8)
- Exclusion Criteria for CA Participant Caregiver:
- Significant visual impairment precluding reading or writing
- No reliable telephone or internet access
Exclusion
Key Trial Info
Start Date :
November 3 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT06930846
Start Date
November 3 2025
End Date
December 1 2028
Last Update
November 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth-Health Lebanon
Lebanon, New Hampshire, United States, 03756